Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Invus Public Equities, L.p.


  • Large Shareholder, Director at Lexicon Pharmaceuticals Inc. (LXRX), 2018-06-29
  • Large Shareholder at Scholar Rock Holding Corp (SRRK), 2018-06-01
  • Large Shareholder at Furiex Pharmaceuticals Inc. (FURX), 2013-02-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LXRX $12.45 57,724 Large Shareholder, Director 3,516,214 2018-06-28 Filing
LXRX $12.54 125,114 Large Shareholder, Director 3,458,490 2018-06-27 Filing
LXRX $12.95 228,264 Large Shareholder, Director 3,333,376 2018-06-25 Filing
LXRX $13.36 25,461 Large Shareholder, Director 3,105,112 2018-06-22 Filing
LXRX $13.27 51,600 Large Shareholder, Director 3,079,651 2018-06-21 Filing